article thumbnail

UK Govt For first time ever allows export of sublingual medical cannabis oil tinctures into the UK.

Cannabis Law Report

LYPHE Group has secured an emergency planning agreement with the Home Office and the Office of Medicinal Cannabis in the Netherlands to allow for the first time ever the export of sublingual medical cannabis oil tinctures for patients into the UK. This could not be further from reality. LYPHE Group secures COVID-19 agreement.

article thumbnail

New Title: Canada McGill – Queens University Press: Remedicalising Cannabis Science, Industry, and Drug Policy By Suzanne Taylor

Cannabis Law Report

When cannabis tincture was withdrawn from the medical establishment in the UK in 1973, cannabis became regulated solely as an illicit drug. A contemporary history of the remedicalization of cannabis and the shifting boundaries between licit and illicit drugs. Within a decade cannabis-based drugs were back in the clinic.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

The Evolution of Medical Marijuana: From Stigma to Acceptance in the US

MMJ Recs

Cannabis was commonly utilized in various medicinal preparations and tinctures, and it was listed in the US Pharmacopeia until the early 20th century. Legalization and Regulation of Medical Marijuana The journey of legalizing and regulating medical marijuana in the US reflects a nuanced interplay of federal and state policies.

article thumbnail

Philippines: Cannabis bills likely to be indefinitely postponed

Cannabis Law Report

The main roadblock is President Rodrigo Duterte’s controversial anti-drug policy – popularly called the ‘war on drugs’ – which has attracted criticism from human rights advocates because of the rising number of extra-judicial killings. Read the full article at.

article thumbnail

State restrictions on cannabis packaging worry producers

Cannabis Chronicles

Because of state regulations, the packaging for the company’s infused tinctures, topicals, capsules and other products contains no information claiming any therapeutic effects. The policy bars cannabis companies from making any statement or reference about their products impacting consumers’ health or having “an effect on the body or mind.”

Packaging 100
article thumbnail

FDA Stresses CBD Safety Concerns in 15 Warning Letters and Revised Consumer Update

The Blunt Truth

The letters also explain that because CBD is an active ingredient in the epilepsy drug, Epidiolex , products containing CBD are therefore outside the definition of a dietary supplement and cannot be added to food products.

Safety 68
article thumbnail

What is CBD? Everything you need to know

The Cannigma

Cannabis products such as oils, tinctures and creams are usually decarboxylated as part of their preparation. The first clinical research done on CBD as a potential treatment for epilepsy was in 1980, but the information gleaned didn’t make its way to the public eye until decades later. Shutterstock). It’s everywhere.

CBD 122